Breast cancer index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—to offer more? (aTTom) trial
J M S Bartlett, D C Sgroi, K Treuner, Y Zhang, I Ahmed, T Piper, R Salunga, E F Brachtel, S J Pirrie, C A Schnabel, D W Rea
Research output: Contribution to journal › Article › peer-review
24Citations
(Scopus)
183Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Breast cancer index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—to offer more? (aTTom) trial'. Together they form a unique fingerprint.